1995
DOI: 10.1007/bf01571196
|View full text |Cite
|
Sign up to set email alerts
|

How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2001
2001
2009
2009

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 76 publications
0
2
0
Order By: Relevance
“…5‐Fluorouracil (5‐FU) has been used for varieties of cancers including colorectal cancer 15. It is administered parenterally because oral administration of the drug shows low and variable bioavailability due to the incomplete absorption and marked bioinactivation by dihydrouracil dehydrogenase in the liver and the mucosal membrane of the gastrointestinal tract 16.…”
Section: Introductionmentioning
confidence: 99%
“…5‐Fluorouracil (5‐FU) has been used for varieties of cancers including colorectal cancer 15. It is administered parenterally because oral administration of the drug shows low and variable bioavailability due to the incomplete absorption and marked bioinactivation by dihydrouracil dehydrogenase in the liver and the mucosal membrane of the gastrointestinal tract 16.…”
Section: Introductionmentioning
confidence: 99%
“…5-Fluorouracil (5-FU) is an antimetabolite of the pyrimidine analogue type, which is frequently used for treating solid tumors, such as colorectal, gastric tract, and liver carcinomas [ 1 , 2 , 3 ]. However, the clinical applications of 5-FU are greatly limited by its short plasma half-life, poor tumor affinity, myelosuppression, and strong intestinal toxicity.…”
Section: Introductionmentioning
confidence: 99%